Merck KGaA secures CRISPR patents in Japan and Singapore

The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Merck expands CRISPR patent portfolio

12 May 2020 Merck has added two US patents to its CRISPR-Cas9 patent portfolio, and is already seeking licensing and product development partners, the German company announced yesterday, May 11.

Americas

Merck KGaA secures second US CRISPR patent

9 April 2020 Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23.

Big Pharma

UK firm successfully challenges ‘Vagisan’ TM in Singapore

28 February 2020 UK-based pharmaceutical manufacturer Comb International, owner of the ‘Vagisil’ trademark, has successfully challenged the ‘Vagisan’ trademark at the Intellectual Property Office Singapore.

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Merck KGaA secures CRISPR patents in Japan and Singapore

More on this story

Editor's picks

Editor's picks

More features